Eckert & Ziegler: capital increase successfully concluded / clear oversubscription
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Capital Increase
Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
Berlin, 4 February 2009 – The Berlin based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) has successfully concluded its capital increase for cash. The company has increased its capital stock by 19.3%. 628,633 shares were thereby placed at a subscription price of 5.00 EUR each. The subscription period for the shareholders ended on 3 February 2009. After registering and implementing the capital increase in the commercial register the capital stock amounts to 3,878,633 EUR, divided into 3,878,633 shares. After the completion of the securities prospectus the new shares will be permitted to be traded on the Frankfurt Stock Exchange (Prime Standard).
With the capital increase around 3.1 million EUR flow into the company that will be used for the recently announced purchase of the Braunschweig isotope specialists nuclitec GmbH. 'The clear oversubscription in excess of 50% underlines the great trust investors have in the company and our business model', explained Dr Andreas Eckert, Chairman of the Board at Eckert & Ziegler AG. The capital increase, was accompanied by BankM – representation of biw Bank für Investments und Wertpapiere AG.
Eckert & Ziegler AG, which achieved a turnover of approx. 70 million EUR in 2008 with around 410 employees, is one of the world’s largest providers of isotopic components for radiation therapy and nuclear medicine.
Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax -112
E-Mail: karolin.riehle@ezag.de, www.ezag.de
04.02.2009 Financial News transmitted by DGAP
Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Hamburg, Düsseldorf
End of News DGAP News-Service